1-[N-(4-CHLOROPHENYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXYCARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER
Compound with spectra: 1 NMR
![1-[N-(4-CHLOROPHENYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXYCARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER](/api/compound/F5gTfU66YJO.png?ph=true&h=300&w=458 "1-[N-(4-CHLOROPHENYLMETHYL)-PIPERAZINYL-2-ETHYLAMIDO]-N-BENZYLOXYCARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER")
| SpectraBase Compound ID | F5gTfU66YJO |
|---|---|
| InChI | InChI=1S/C28H37ClN4O5/c1-2-37-26(34)13-12-25(31-28(36)38-21-23-6-4-3-5-7-23)27(35)30-14-15-32-16-18-33(19-17-32)20-22-8-10-24(29)11-9-22/h3-11,25H,2,12-21H2,1H3,(H,30,35)(H,31,36)/t25-/m0/s1 |
| InChIKey | WYSCZPSNUAQDCC-VWLOTQADSA-N |
| Mol Weight | 545.1 g/mol |
| Molecular Formula | C28H37ClN4O5 |
| Exact Mass | 544.245248 g/mol |
| Enantiomer InChIKey | WYSCZPSNUAQDCC-RUZDIDTESA-N |
| Racemate InChIKey | WYSCZPSNUAQDCC-UHFFFAOYSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
1-(N-BENZYLPIPERIDIN-4-YL-2-ETHYLAMIDO)-N-BENZYLOXY-CARBONYL-S-GLUTAMIC-ACID-5-ETHYLESTER
N-[(BENZYLOXY)-CARBONYL]-L-GLUTAMINYL-L-PHENYLALANINOL
benzyl 4-amino-4-oxo-1-(3-toluidinocarbonyl)butylcarbamate
ETHYL-N-(BENZYLOXYCARBONYL)-TYROSYLGLYCYLGLYCINE
benzyl (5S)-6-{[(1S)-1-(aminocarbonyl)-2-methylpropyl]amino}-5-{[(benzyloxy)carbonyl]amino}-6-oxohexylcarbamate
N-[(BENZYLOXY)-CARBONYL]-L-LEUCYL-2-METHYLALANINE-DIMETHYLAMIDE
BENZYLOXYCARBONYL-VALINE-GLYCINE-(TERT-BUTYLOXYCARBONYL)LYSINETRIPEPTIDE
Benzyl 1-benzyl-2-{[2-(2,6-dimethylphenoxy)ethyl]amino}-2-oxoethylcarbamate
N-[(N2-benzyloxycarbonyl-N4-nitro)-L-arcinyl]-L-valine
METHYL-N-(BENZYLOXYCARBONYL)-LEUCYLALANYLALANINE
| Title | Journal or Book | Year |
|---|---|---|
| Lipase-catalysed synthesis of new acetylcholinesterase inhibitors: N-benzylpiperidine aminoacid derivatives | Bioorganic & Medicinal Chemistry | 2000 |